Stryker pledges to fix its Europe problem news

Stryker (NYSE:SYK) has brushed off economic troubles in the U.S. for several quarters, but it has a European crisis of its own to deal with, company officials reiterated yesterday during the medical device company’s annual analyst day in Mahwah, N.J.

Ramesh Subrahmanian, the company’s international group president, said Stryker’s troubles in Europe go beyond the weak economy there, vowing to work hard to improve the company’s performance across the pond.

"I want to clearly acknowledge that Stryker has a significant challenge and we have lagged the European market situation for sure," Subrahmanian said.

Sign up to get our free newsletters delivered right to your inbox

Stryker derived about 37% of its roughly $8 billion in sales in 2011 from international markets, from strong positions in Japan, Australia, Canada and parts of Western Europe.

But the bulk of the company’s sales come from inside the U.S., higher than its peers in the med-tech space which derive about 58% of their sales from international markets.

"Clearly, we are under-represented in international markets," Subrahmanian said.

A year into his tenure as the Kalamazoo, Mich.-based company’s international business leader, he said he’s looking to emerging markets such as China, India, Russia and Turkey as long-term growth drivers of for Stryker.

First up, however is a push to improve Stryker’s lagging performance in the European Union.

"Over the last few years, our European business has not kept pace with our own expectations," Subrahmanian said. "There are significant challenges in the EU market for sure."

It’s not the first time that Stryker has acknowledged problems with its EU operations. In a conference call with investors in July, interim CEO Curt Hartman told Leerink Swann analyst Richard Newitter that the company’s shortcomings in the EU were partly its own doing.

"We’ve had a number of ongoing organizational changes that we are working our way through, the right changes and the right structure moves to address where we see the European market moving to. And it’s been a bit of a moving target over the last couple of years for us and part of that is external environment focus," Hartman said at the time. "But we have to be intellectually honest. Part of that is our failure to execute, and we’re still a little bit playing catch-up to where the market is going and where we think we need to be.

"There’s no quick solution here. We’ve been working on this for far too long, frankly, and we just got to pay more attention to it," he said, noting that Stryker has lost market share to competitors such as Johnson & Johnson (NYSE:JNJ).

Subrahmanian said yesterday that improving market share in the EU is be a multi-stage process of re-organizing the operations and distributions channels in Southern Europe, addressing the company’s weakness in Germany and "leveraging the company’s full portfolio" while launching new products in those markets.

Long-term, he added, Stryker will look to continue its growth in emerging markets. The company derives only 6% of sales from developing nations.

"Any serious player must win in those top 5 markets," Subrahmanian said.

Although some analysts wondered if the annual meeting would be the occasion to announce a new CEO (or remoive the "interim" from Hartman’s title), there was no mention of a permanent replacement for Stephebn MacMillan, who’s abrupt ouster in February shocked med-tech.

Hartman did take care, however, to stress the experience of Stryker’s management team, which altogether boasts more than "100 years of Stryker experience."

"If you add up the broader med-tech experience of the group, it’s closer to 150 years," he told the assembled analysts. "[I]t is a seasoned med-tech team, and I think that’s very important in today’s environment, that you understand the management and leadership style that this group brings to the table each and every day."

RSS From Medical Design & Outsourcing

  • Molex delivers ISO 13485-compliant, medical-grade surgical cables from its class 100,000 clean room facility
    Molex, LLC operates a fully ISO 146441-1:1999 Class 8-certified clean room, satisfying strict particulate contamination levels specified by ISO-compliant requirements. Located in Thailand, the facility has less than 100,000 particulates (≥0.5µm) per cubic foot of air and manufactures a variety of ISO 13485-compliant medical cables and surgical cables used in operating theatres, hospitals, laboratories and […]
  • Swept-Source OCT: Patent license agreement between Massachusetts General Hospital and Heidelberg Engineering
    Heidelberg Engineering has entered into a patent license agreement with Massachusetts General Hospital (MGH) in Boston. The agreement grants global and exclusive rights to 77 basic patents and patent applications which relate to swept-source OCT technology and its application in ophthalmology. Spectral domain OCT has become indispensable to eye care professionals worldwide to diagnose and […]
  • MIT’s MultiFab presents a stark challenge to incumbent 3D Printer manufacturers’ hardware, software, and business Models
    MIT’s Computational Fabrication Group recently announced the MultiFab, a low-cost 3D printer that can combine up to 10 different resins in one part and also includes a 3D scanning system to identify and fix errors during production. According to Lux Research, these capabilities are rare in commercial 3D printers today due to the manufacturers’ need […]
  • AVX releases Accu-P MP medical grade film chip capacitors for medical devices
    AVX Corporation, a leading manufacturer of passive components and interconnect solutions, has released a new series of thin film chip capacitors specifically designed to meet the demanding performance specifications for implantable medical devices. Delivering extremely tight capacitive tolerances, exceptionally repeatable performance, and remarkably low ESR and high Q at high frequencies—including VHF, UHF, and RF […]
  • RIVANNA commences manufacturing of its Accuro device
    Rivanna Medical announced that it has begun manufacturing its FDA-cleared Accuro device, a handheld and untethered smart-phone-sized device that is designed to guide spinal anesthesia with automated 3D navigation technology in addition to ultrasound imaging of abdominal, musculoskeletal, cardiac and peripheral vascular anatomies. The product will be launched at the ASA annual meeting in San […]
  • FDA seeks public input on Quality Metrics guidance
    by Oliver Wolf, Senior Product Manager, MasterControl In line with the general shift towards risk-driven approaches in the quality management world, FDA is now taking steps towards applying those same principles to its own auditing schedule. At the end of July, the Center for Drug Evaluation and Research (CDER) and the Center for Biologics Evaluation […]
  • First ‘Ear Wear’ for Active Adults Debuts with MDHearingAid FIT
    If you’ve burned out your ears with earbuds, headphones or decades of other audio abuse but aren’t ready for your grandmother’s hearing aids, not to worry! The new MDHearingAid FIT gets you back in the game with a tiny, FDA-registered, one-size-fits-most solution that doesn’t block your ear canal like old-fashioned in-the-ear hearing aids. The FIT feels […]
  • CardioGenics enters into manufacturing agreement with Ontario-based Plasticap
    CardioGenics Holdings, developer for the In-Vitro-Diagnostics (“IVD”) testing market, announced that it has entered into a manufacturing agreement with Plasticap of Ontario, Canada, pursuant to which Plasticap will manufacture CardioGenics’ proprietary self-metering cartridges for its QL Care analyzer. The term of the agreement is three years and the purchase price for each cartridge shall be […]
  • MTD Micro Molding releases micro materials menu
    MTD Micro Molding, a long-time leader in micro-injection molding, has released an updated “Materials Menu” of materials that can be successfully micromolded to help guide engineers at medical device companies. Material selection is a crucial step in product manufacturability. The correct material drives tolerance, dimension, strength, usabality, speed-to-market, design, critical features, and cost. Through MTD’s […]
  • MedTech Chat: Elastic technology for drug delivery
    Dr. Zhen Gu and Dr. Yong Zhu from North Carolina State University are both co-senior authors of a research paper describing their recent work. Dr. Gu, Dr. Zhu and other researchers from North Carolina State University and the University of North Carolina at Chapel Hill have developed a drug delivery technology that consists of an […]
  • B. Braun’s OEM Division offers large bore normally closed low-pressure check valves
    Infusion therapy and pain management device manufacturer B. Braun said today it is offering normally closed large-bore low-pressure check valves through its valve-focused contract manufacturing OEM division. The valves, offered by Bethlehem, Pa.-based B. Braun, are designed for the intermittent injection of fluids during medical treatment and open automatically when pressure is applied. The newly […]

Leave a Reply